Free Trial

GE HealthCare Technologies (GEHC) 10K Form and Latest SEC Filings 2026

GE HealthCare Technologies logo
$61.74 +0.70 (+1.15%)
Closing price 04:00 PM Eastern
Extended Trading
$61.89 +0.15 (+0.25%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest GE HealthCare Technologies SEC Filings & Recent Activity

GE HealthCare Technologies (NASDAQ:GEHC) has submitted 295+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in GE HealthCare Technologies's financial statements. The most recent filing was a Form 3 submitted on May 5, 2026.

Form 4
GE HealthCare Technologies Inc. Reports Ownership Change on May. 1, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
GE HealthCare Technologies Files Current Report on Apr. 29, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
GE HealthCare Technologies Files Quarterly Report on Apr. 29, 2026

The 10-Q contains GE HealthCare Technologies's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

GE HealthCare Technologies SEC Filing History

Browse GE HealthCare Technologies' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/05/2026 7:15 AM
Estrampes Catherine (2131383) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 3
Initial statement of beneficial ownership of securities  
05/01/2026 10:38 AM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 3:20 PM
Arduini Peter J (1323134) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 3:21 PM
GE HealthCare Technologies (1932393) Issuer
Jimenez Frank R (1465175) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 5:39 PM
GE HealthCare Technologies (1932393) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/29/2026 5:25 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 5:26 AM
GE HealthCare Technologies (1932393) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/26/2026 5:37 PM
GE HealthCare Technologies (1932393) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/19/2026 6:02 AM
GE HealthCare Technologies (1932393) Filer
Form DEF 14A
03/19/2026 6:03 AM
GE HealthCare Technologies (1932393) Filer
Form DEFA14A
03/19/2026 6:06 AM
GE HealthCare Technologies (1932393) Filer
Form ARS
03/17/2026 8:14 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 3:22 PM
Arduini Peter J (1323134) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 3:23 PM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 3:23 PM
GE HealthCare Technologies (1932393) Issuer
Rott Roland (1952159) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 3:24 PM
GE HealthCare Technologies (1932393) Issuer
Rackliffe Philip (2027284) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:13 PM
Arduini Peter J (1323134) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:14 PM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:15 PM
GE HealthCare Technologies (1932393) Issuer
Jimenez Frank R (1465175) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:15 PM
GE HealthCare Technologies (1932393) Issuer
Kass-Hout Taha (1960652) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:16 PM
GE HealthCare Technologies (1932393) Issuer
Rott Roland (1952159) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:17 PM
GE HealthCare Technologies (1932393) Issuer
Rackliffe Philip (2027284) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:17 PM
GE HealthCare Technologies (1932393) Issuer
O'Neill Kevin Michael (1951605) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 6:18 PM
GE HealthCare Technologies (1932393) Issuer
Newcomb George A. (1952158) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:22 PM
DODGE & COX (200217) Filed by
GE HealthCare Technologies (1932393) Subject
Form SCHEDULE 13G/A
02/04/2026 5:25 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2026 5:28 AM
GE HealthCare Technologies (1932393) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/03/2026 5:54 PM
GE HealthCare Technologies (1932393) Issuer
Jimenez Frank R (1465175) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 5:56 PM
GE HealthCare Technologies (1932393) Issuer
Rott Roland (1952159) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 5:58 PM
GE HealthCare Technologies (1932393) Issuer
Newcomb George A. (1952158) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 6:01 PM
GE HealthCare Technologies (1932393) Issuer
Kass-Hout Taha (1960652) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 6:02 PM
GE HealthCare Technologies (1932393) Issuer
Rackliffe Philip (2027284) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 6:03 PM
GE HealthCare Technologies (1932393) Issuer
O'Neill Kevin Michael (1951605) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 5:51 PM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 5:47 PM
Arduini Peter J (1323134) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 4:02 PM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2025 4:11 PM
GE HealthCare Technologies (1932393) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
12/02/2025 3:55 PM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 7:40 AM
GE HealthCare Technologies (1932393) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
11/24/2025 3:24 PM
GE HealthCare Technologies (1932393) Subject
Stacherski Kenneth R. (1889865) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2025 9:29 AM
Capital Research Global Investors (1422848) Filed by
GE HealthCare Technologies (1932393) Subject
Form SCHEDULE 13G
10/29/2025 5:25 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2025 5:26 AM
GE HealthCare Technologies (1932393) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2025 3:26 PM
GE HealthCare Technologies (1932393) Subject
Stacherski Kenneth R. (1889865) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2025 3:44 PM
GE HealthCare Technologies (1932393) Subject
Stacherski Kenneth R. (1889865) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2025 3:47 PM
GE HealthCare Technologies (1932393) Subject
Stacherski Kenneth R. (1889865) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025 3:11 PM
Arduini Peter J (1323134) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:12 PM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:13 PM
GE HealthCare Technologies (1932393) Issuer
Jimenez Frank R (1465175) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:15 PM
GE HealthCare Technologies (1932393) Issuer
Rott Roland (1952159) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:16 PM
GE HealthCare Technologies (1932393) Issuer
Rackliffe Philip (2027284) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:17 PM
GE HealthCare Technologies (1932393) Issuer
Kass-Hout Taha (1960652) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:18 PM
GE HealthCare Technologies (1932393) Issuer
Holton Adam Y (1657919) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025 7:10 AM
GE HealthCare Technologies (1932393) Issuer
Stacherski Kenneth R. (1889865) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025 5:25 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025 5:27 AM
GE HealthCare Technologies (1932393) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2025 3:33 PM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025 10:26 AM
Capital Research Global Investors (1422848) Filed by
GE HealthCare Technologies (1932393) Subject
Form SCHEDULE 13G/A
06/04/2025 3:50 PM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025 3:08 PM
GE HealthCare Technologies (1932393) Issuer
SACCARO JAMES (1593636) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025 8:14 AM
GE HealthCare Technologies (1932393) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
05/30/2025 4:46 PM
GE HealthCare Technologies (1932393) Issuer
Hochman Rodney F (1468966) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:50 PM
GE HealthCare Technologies (1932393) Issuer
Mihaljevic Tomislav (1917584) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:54 PM
GE HealthCare Technologies (1932393) Issuer
Madden Anne T (1684059) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:57 PM
GE HealthCare Technologies (1932393) Issuer
HOWELL LLOYD JR (1505488) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 5:00 PM
GE HealthCare Technologies (1932393) Issuer
LESJAK CATHERINE A (1256992) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 5:05 PM
GE HealthCare Technologies (1932393) Issuer
LAVIZZO-MOUREY RISA J (1034465) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:26 PM
CULP H LAWRENCE JR (1205247) Reporting
GE HealthCare Technologies (1932393) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:38 PM
GE HealthCare Technologies (1932393) Issuer
Stromberg William J (1352578) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:42 PM
GE HealthCare Technologies (1932393) Issuer
Yang Watkin Phoebe L. (1940538) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 7:59 AM
GE HealthCare Technologies (1932393) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025 3:15 PM
GE HealthCare Technologies (1932393) Filer
Form SD
Specialized Disclosure Report  
05/13/2025 10:32 AM
Capital Research Global Investors (1422848) Filed by
GE HealthCare Technologies (1932393) Subject
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)

GE HealthCare Technologies SEC Filings - Frequently Asked Questions

GE HealthCare Technologies (GEHC) has submitted 295+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above.

GE HealthCare Technologies's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on GE HealthCare Technologies's financial statements page.

The most recent filing was a Form 3 submitted on May 5, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:GEHC) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners